Our Team
CureDiab has a fully operative team in place including an outstanding scientific advisory board, external scientific consultant, and an experienced lab team. The founder of CureDiab, Prof. Juergen Eckel, acts as CEO and Dr. Elisabeth Rohbeck supports the team as CSO.
"Our vision is nothing more than the Cure for Diabetes..."
Juergen is Professor of Clinical Biochemistry
at the German Diabetes Center with more than
40 years of experience in metabolic research.
He holds several patents and has authored
more than 200 scientific publications.
Prof. Dr. Juergen Eckel
Chief Executive Officer
"Innovation defines our Future"
Elisabeth is a molecular biologist with a broad expertise
in the pathophysiology of metabolic disorders and specifically
trained for drug development management in preclinical phase.
During her PhD she focused on pharmacological interventions
for MASLD, including our lead compound.
Dr. Elisabeth Rohbeck
Chief Scientific Officer
"Cost today, value tomorrow"
Ruediger is a seasoned financial expert with over 30 years of experience as a CFO and Business Consultant across multiple industries. In the past 15 years, he has served as Interim Finance CFO, Head of Controlling, Accounting, and Treasury, primarily in the Biotech, Chemical, Production, Trade, Services, and Media sectors. His core competencies include financial planning & analysis, cash management, and financing. Ruediger currently supports CureDiab as a fractional or part-time CFO.
Dr. Ruediger Tiedemann
Consulting CFO
"Translating complex Science into a viable Business Proposition"
Steven has had a long career and accumulated a broad expertise as scientist, entrepreneur and founder. He was one of the first biotech analysts on Wall Street and transitioned into investment banking and portfolio management, all in healthcare and life sciences with firms such as F. Eberstadt & Co, Robert Fleming, Donaldson, Lufkin & Jenrette and Credit Suisse First Boston. He was a co-founder of Protein Sciences, a vaccine company acquired by Sanofi in 2017. He is a co-founder and Acting CEO of Dark Matter Therapeutics Inc., an innovative AI Drug discovery company.
Steven Zimmer
Advisor
Consulting
USAScott L. Friedman, M.D.
Experienced professor in the field of hepatology and pioneer in liver fibrosis research
GermanyGranzer Regulatory Consulting & Services
Offering expert guidance for tailor-made global drug development
Scientific Advisory Board
GermanyProf. Dr. Michael Roden
He is the Scientific Director of the German Diabetes Center and an internationally recognised expert in the field of fatty liver.
GermanyProf. Dr. Dr. Hans-Georg Joost
He was the President of the German Diabetes Association, Scientific Director of the German Institute of human Nutrition and a member of Leopoldina.
GermanyProf. Dr. Diethelm Tschöpe
He is the Director of the Diabetes Center Bad Oeynhausen and an expert in experimental and clinical cardio-vascular biology and complications.
IsraelProf. Dr. Arie-Lev Gruzman
He is a professor of chemistry at Bar Ilan University specializing in Medicinal Chemistry.
© 2022 cureDiab All rights reserved